Report cover image

Nicotinamide Adenine Dinucleotide Products Market Size, Share & Trends Analysis Report By Product (Oral Supplements, Topical Products), By Distribution Channel (Hypermarkets & Supermarkets, Pharmacies & Drug Stores), By Region, And Segment Forecasts, 2025

Publisher Grand View Research
Published Oct 30, 2025
Length 109 Pages
SKU # GV20575209

Description

Nicotinamide Adenine Dinucleotide Products Market Summary

The global nicotinamide adenine dinucleotide products market size was valued at USD 3,451.16 million in 2024 and is expected to reach USD 12,187.24 million by 2033, growing at a CAGR of 15.1% from 2025 to 2033. The nicotinamide adenine dinucleotide (NAD) products industry is driven by increasing awareness of its role in cellular energy production, DNA repair, and healthy aging.

Consumers are seeking supplements that support vitality, cognitive function, and metabolic health, especially as interest in longevity and preventive wellness grows. Additionally, ongoing research linking NAD levels to age-related conditions has further fueled demand in the nutraceutical and wellness markets.

The popularity of NAD-boosting supplements like NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) has increased, driven by interest in healthy aging and cognitive support. Brands such as Tru Niagen and Elysium Health have capitalized on this trend, offering products that claim to enhance energy, focus, and resilience against age-related decline.

NAD products are also seeing wider use beyond supplements, appearing in IV therapy, skincare, and functional beverages, making them more accessible and appealing to a broader audience. As clinical research and consumer demand continue to grow, NAD is becoming a key ingredient in the evolving wellness and anti-aging space. For instance, in May 2025, Eden, a leading metabolic health platform, launched U.S.-wide access to a prescription-only NAD+ 10% Face Cream through its telehealth service.

The NAD products industry is expanding well beyond traditional oral supplements, with brands exploring new delivery formats to improve efficacy, user experience, and market appeal. While capsules and tablets containing precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN) remain the most common format, newer options such as liposomal formulations, sustained-release tablets, and sublingual powders are gaining popularity for their potential to enhance bioavailability. These innovations not only cater to consumer demand for more effective dosing but also allow brands to differentiate in a crowded market.

For instance, in January 2025, Renue by Science introduced a new skincare line called Renue Blue, which focuses on skin wellness and longevity through the use of liposomal NAD (Nicotinamide Adenine Dinucleotide). The product line aims to leverage the benefits of NAD, a coenzyme crucial for cellular functions, in a topical format to promote skin health. The liposomal delivery system is designed to enhance the absorption and effectiveness of NAD in the skin.

Nicotinamide Adenine Dinucleotide Products Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nicotinamide adenine dinucleotide products market report on the basis of product, distribution channel, and region.
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral Supplements
  • Capsules/Tablets
  • Powders
  • Energy Drinks
  • Topical Products
  • Creams & Serums
  • Eye Cream & Lip Balms
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hypermarkets & Supermarkets
  • Pharmacies & Drug Stores
  • Online
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Taiwan
  • South Korea
  • Central & South America
  • Brazil
  • Middle East & Africa
  • UAE
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

109 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Materials & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product Outlook
2.3. Distribution Channel Outlook
2.4. Regional Outlook
2.5. Competitive Landscape Snapshot
Chapter 3. Nicotinamide Adenine Dinucleotide (NAD) Products Market Variables and Trends
3.1. Market Introduction
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Trends & Outlook
3.2.2. Retail/Sales Channel Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Consumer Behavior Analysis
4.1. Demographic Analysis
4.2. Consumer Trends & Preferences
4.3. Factors Affecting Buying Decisions
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
Chapter 5. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Product Estimates & Trend Analysis
5.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Product: Key Takeaways
5.2. Product Movement Analysis & Market Share, 2024 & 2033
5.3. Market Estimates & Forecasts by Product, 2021 - 2033 (USD Million)
5.3.1. Oral Supplements
5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.1.1.1. Capsules/Tablets
5.3.1.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.1.1.2. Powders
5.3.1.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.1.1.3. Energy Drinks
5.3.1.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.2. Topical Products
5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.2.1.1. Creams & Serums
5.3.2.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.2.1.2. Eye Cream & Lip Balms
5.3.2.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.3.3. Others
5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Distribution Channel Estimates & Trend Analysis
6.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Distribution Channel: Key Takeaways
6.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2033
6.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
6.3.1. Hypermarkets & Supermarkets
6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.3.2. Pharmacies & Drug Stores
6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.3.3. Online
6.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.3.4. Others
6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 7. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2024 & 2033
7.2. North America
7.2.1. U.S.
7.2.1.1. Key country dynamics
7.2.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.2.2. Canada
7.2.2.1. Key country dynamics
7.2.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.2.3. Mexico
7.2.3.1. Key country dynamics
7.2.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.3. Europe
7.3.1. U.K.
7.3.1.1. Key country dynamics
7.3.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.3.2. Germany
7.3.2.1. Key country dynamics
7.3.2.2. Key country dynamics
7.3.2.3.Market estimates and forecast, 2021 - 2033 (USD Million)
7.3.3. France
7.3.3.1. Key country dynamics
7.3.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.3.4. Italy
7.3.4.1. Key country dynamics
7.3.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.3.5. Spain
7.3.5.1. Key country dynamics
7.3.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.4. Asia Pacific
7.4.1. China
7.4.1.1. Key country dynamics
7.4.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.4.2. India
7.4.2.1. Key country dynamics
7.4.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.4.3. Japan
7.4.3.1. Key country dynamics
7.4.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.4.4. Australia & New Zealand
7.4.4.1. Key country dynamics
7.4.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.4.5. Taiwan
7.4.5.1. Key country dynamics
7.4.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.4.6. South Korea
7.4.6.1. Key country dynamics
7.4.6.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.5. Central & South America
7.5.1. Brazil
7.5.1.1. Key country dynamics
7.5.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
7.6. Middle East & Africa
7.6.1. UAE
7.6.1.1. Key country dynamics
7.6.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 8. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Competitive Analysis
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2024 (%)
8.7. Company Heat Map Analysis, 2024
8.8. Strategy Mapping
8.9. Company Profiles
8.9.1. Core Med Science
8.9.1.1. Company Overview
8.9.1.2. Financial Performance
8.9.1.3. Product Portfolios
8.9.1.4. Strategic Initiatives
8.9.2. Niagen Bioscience, Inc.
8.9.2.1. Company Overview
8.9.2.2. Financial Performance
8.9.2.3. Product Portfolios
8.9.2.4. Strategic Initiatives
8.9.3. Elysium Health
8.9.3.1. Company Overview
8.9.3.2. Financial Performance
8.9.3.3. Product Portfolios
8.9.3.4. Strategic Initiatives
8.9.4. Thorne
8.9.4.1. Company Overview
8.9.4.2. Financial Performance
8.9.4.3. Product Portfolios
8.9.4.4. Strategic Initiatives
8.9.5. Cata-Kor NAD
8.9.5.1. Company Overview
8.9.5.2. Financial Performance
8.9.5.3. Product Portfolios
8.9.5.4. Strategic Initiatives
8.9.6. Life Extension
8.9.6.1. Company Overview
8.9.6.2. Financial Performance
8.9.6.3. Product Portfolios
8.9.6.4. Strategic Initiatives
8.9.7. Wonderfeel
8.9.7.1. Company Overview
8.9.7.2. Financial Performance
8.9.7.3. Product Portfolios
8.9.7.4. Strategic Initiatives
8.9.8. Nutricost
8.9.8.1. Company Overview
8.9.8.2. Financial Performance
8.9.8.3. Product Portfolios
8.9.8.4. Strategic Initiatives
8.9.9. RENUE BY SCIENCE, Inc.
8.9.9.1. Company Overview
8.9.9.2. Financial Performance
8.9.9.3. Product Portfolios
8.9.9.4. Strategic Initiatives
8.9.10. Codeage LLC
8.9.10.1. Company Overview
8.9.10.2. Financial Performance
8.9.10.3. Product Portfolios
8.9.10.4. Strategic Initiatives
8.9.11. HPN SUPPLEMENTS
8.9.11.1. Company Overview
8.9.11.2. Financial Performance
8.9.11.3. Product Portfolios
8.9.11.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us